FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of formulae (I) or (II) or pharmaceutically acceptable salts thereof, which have skeleton 2-(1H-pyrazol-1-yl)phenol. In said formulae R4 and R12 denote a hydroxyl group, and R1-R3, R5-R8 and R9-R11, R13-R16 have values given in patent claim.
EFFECT: creation of antifungal agents for dermatophytosis, containing said compounds as an active ingredient.
10 cl, 2 tbl, 64 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOL DERIVATIVES, MEDICAL COMPOSITIONS, CONTAINING THEM, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR PRODUCTION | 2003 |
|
RU2369613C2 |
| ANILIDES OF AMINO ACIDS AS LOW-MOLECULAR MODULATORS IL-17 | 2019 |
|
RU2815505C2 |
| COMPOSITIONS SUITABLE FOR TREATING DISORDERS ASSOCIATED WITH KIT | 2014 |
|
RU2706235C2 |
| NOVEL PHOSPHATE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2617682C2 |
| CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
| 3-ALKYLIDENHYDRAZINO-HETEROARYL COMPOUNDS AS ACTIVATORS OF THROMBOPROTEIN RECEPTOR | 2004 |
|
RU2358970C2 |
| CYCLOALKANE-1,3-DIAMINE DERIVATIVE | 2019 |
|
RU2793247C2 |
| 1,5-NAPHTHRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THEM | 2012 |
|
RU2645339C1 |
| PYRAZOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2016 |
|
RU2687245C1 |
| SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
